Related Experiment Video

Updated: Jun 16, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Underuse of thrombolytic therapy in acute myocardial infarction and left bundle branch block

R Andrew Archbold1, Kulasegarum Ranjadayalan, Abdel Suliman

  • 1Department of Cardiology, Newham University Hospital, London, UK. andrew.archbold@bartsandthelondon.nhs.uk

Clinical Cardiology
|February 16, 2010
PubMed

Insights

Diagnosing acute myocardial infarction (AMI) in patients with left bundle branch block (LBBB) is challenging, leading to undertreatment. Many AMI patients with LBBB do not receive life-saving thrombolytic therapy, while some without AMI are treated inappropriately.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Diagnostics

Background:

  • Thrombolytic therapy is crucial for reducing mortality in acute myocardial infarction (AMI).
  • Left bundle branch block (LBBB) complicates the diagnosis of AMI, potentially leading to undertreatment.
  • Accurate early diagnosis is essential for timely and appropriate treatment of acute coronary syndromes.

Purpose of the Study:

  • To investigate the diagnostic challenges and treatment disparities in patients presenting with chest pain and left bundle branch block (LBBB).
  • To identify factors associated with AMI in patients with LBBB.
  • To evaluate the utilization of thrombolytic therapy in AMI patients with and without LBBB.

Main Methods:

  • Retrospective analysis of 3,890 patients hospitalized with chest pain.
  • Identification of patients with left bundle branch block (LBBB) at presentation.
  • Statistical analysis to determine variables associated with AMI in LBBB patients and compare thrombolytic therapy rates.

Main Results:

  • 6.2% of patients presented with LBBB.
  • In-hospital left ventricular failure was the only independent predictor of AMI in LBBB patients (OR: 4.32).
  • Only 29% of AMI patients with LBBB received thrombolytic therapy, compared to 78% of those with ST-elevation AMI. 10% of LBBB patients without AMI received thrombolysis.

Conclusions:

  • Accurate early diagnosis of AMI in patients with LBBB remains a significant challenge.
  • The majority of AMI patients with LBBB are undertreated with thrombolytic therapy.
  • Improved diagnostic tools and therapeutic strategies are urgently needed for acute coronary syndromes in the presence of LBBB.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...